Live from the NIH registry
Studies recruiting near Minneapolis right now
Top 25 of 1,085 recruiting studies, sorted by proximity — each links to its official registry page
CIBMTR Research Database
Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation
N/A
Observational 99,999,999 participants sought
Center for International Blood and Marrow Transplant Research — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Center for International Blood and Marrow Transplant Research
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Abbott-Northwestern Hospital — Minneapolis, Minnesota (1.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
University of Minnesota — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Syndax Pharmaceuticals
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Minneapolis Heart Institute — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Abbott Medical Devices
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospitals and Clinics of Minnesota - Minneapolis — Minneapolis, Minnesota (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Allina — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Dosentrx Ltd.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
University of Minnesota Medical Center — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Hoffmann-La Roche
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
518 — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Corcept Therapeutics
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
University of Minnesota Medical School — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Azafaros B.V.
Vaped Phenanthrene
Former Smoker, Non-Smoker
N/A
Interventional 100 participants sought
University of Minnesota — Minneapolis, Minnesota (1.2 mi)
· Sponsor: University of Minnesota
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Immunoglobulin A Nephropathy (IgAN)
Phase 2
Interventional 32 participants sought
Inter Med Consultants — Edina, Minnesota (6.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Allina Health Cancer Institute - Abbott Northwestern Hospital — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Eli Lilly and Company
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abbott Northwestern Hospital — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Medtronic Cardiovascular
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Abbott-Northwestern Hospital — Minneapolis, Minnesota (1.2 mi)
· Sponsor: NRG Oncology
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Abbott Northwestern Hospital — Minneapolis, Minnesota (1.2 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University of Minnesota — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Children's Hospital and Clinics of Minnesota — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Giselle Sholler
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Minnesota Oncology Hematology, P.A. — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Kartos Therapeutics, Inc.
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Minneapolis Heart Institute — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Shockwave Medical, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Minnesota Oncology Hematology — Maple Grove, Minnesota (11.9 mi)
· Sponsor: SCRI Development Innovations, LLC
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Minneapolis Heart Institute — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Magenta Medical Ltd.
Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infections
N/A
Interventional 30 participants sought
Regions Hospital — Saint Paul, Minnesota (8.6 mi)
· Sponsor: HealthPartners Institute
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
International Diabetes Center — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
University of Minnesota — Minneapolis, Minnesota (1.2 mi)
· Sponsor: Anagram Therapeutics, Inc.
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
Phase 2
Interventional 54 participants sought
Minnesota Eye Consultants — Minneapolis, Minnesota (1.2 mi)
· Sponsor: TearSolutions, Inc.